Park West Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,000,002
| Closed | -$55M | – | 204 |
|
|
2021
Q2 | $55M | Sell |
6,000,002
-414,983
| -6% | -$2.41M | 1.57% | 16 |
|
|
2021
Q1 | $31.9M | Sell |
6,414,985
-213,772
| -3% | -$1.03M | 0.97% | 29 |
|
|
2020
Q4 | $28.6M | Hold |
6,628,757
| – | – | 0.59% | 42 |
|
|
2020
Q3 | $28.4M | Hold |
6,628,757
| – | – | 1.1% | 34 |
|
|
2020
Q2 | $29.8M | Sell |
6,628,757
-115,136
| -2% | -$515K | 1.47% | 22 |
|
|
2020
Q1 | $27M | Hold |
6,743,893
| – | – | 1.83% | 20 |
|
|
2019
Q4 | $57.2M | Hold |
6,743,893
| – | – | 2.41% | 15 |
|
|
2019
Q3 | $46.2M | Hold |
6,743,893
| – | – | 2.25% | 13 |
|
|
2019
Q2 | $56.2M | Hold |
6,743,893
| – | – | 2.33% | 15 |
|
|
2019
Q1 | $61.8M | Buy |
6,743,893
+741,840
| +12% | +$7.53M | 2.71% | 9 |
|
|
2018
Q4 | $65.7M | Hold |
6,002,053
| – | – | 3.25% | 6 |
|
|
2018
Q3 | $83.7M | Hold |
6,002,053
| – | – | 3.05% | 8 |
|
|
2018
Q2 | $63.9M | Buy |
6,002,053
+845,262
| +16% | +$8.24M | 2.38% | 13 |
|
|
2018
Q1 | $44.6M | Hold |
5,156,791
| – | – | 1.99% | 16 |
|
|
2017
Q4 | $48.7M | Hold |
5,156,791
| – | – | 2.22% | 15 |
|
|
2017
Q3 | $40.5M | Buy |
5,156,791
+600,000
| +13% | +$4.5M | 2.41% | 15 |
|
|
2017
Q2 | $39.2M | Buy |
4,556,791
+170,387
| +4% | +$1.22M | 2.17% | 16 |
|
|
2017
Q1 | $30.9M | Buy |
4,386,404
+2,397,320
| +121% | +$15M | 1.8% | 18 |
|
|
2016
Q4 | $8.45M | Buy |
1,989,084
+38,295
| +2% | +$185K | 0.65% | 42 |
|
|
2016
Q3 | $9.73M | Buy |
1,950,789
+789
| +0% | +$3.33K | 0.89% | 34 |
|
|
2016
Q2 | $6.9M | Buy |
1,950,000
+196,300
| +11% | +$722K | 0.7% | 42 |
|
|
2016
Q1 | $6.05M | Hold |
1,753,700
| – | – | 0.57% | 41 |
|
|
2015
Q4 | $5.96M | Buy |
1,753,700
+1,461,032
| +499% | +$6.78M | 0.64% | 43 |
|
|
2015
Q3 | $1.52M | Buy |
+292,668
| New | +$1.8M | 0.14% | 63 |
|
|
2014
Q4 | – | Sell |
-234,997
| Closed | -$2.17M | – | 58 |
|
|
2014
Q3 | $2.17M | Hold |
234,997
| – | – | 0.32% | 42 |
|
|
2014
Q2 | $4.38M | Buy |
234,997
+24,537
| +12% | +$417K | 0.57% | 42 |
|
|
2014
Q1 | $3.9M | Buy |
+210,460
| New | +$4.01M | 0.44% | 49 |
|
Other funds holding KIN
Park West Asset Management's KIN Position: Q3 2021 in Review
Park West Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 6,000,002 shares — an estimated $55M sold.
Park West Asset Management first reported a position in KIN in Q1 2014 and held it in 27 quarters. The position peaked at $83.7M in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Park West Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Park West Asset Management sold 6,000,002 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $55M.
- Park West Asset Management first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 27 quarters.
- Park West Asset Management's Kindred Biosciences, Inc. position peaked at $83.7M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Park West Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.